UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 74

Sortiert nach

Non‐alcoholic fatty liver disease and type 2 diabetes: An update

Journal of diabetes investigation, 2022-06, Vol.13 (6), p.930-940

2022

Volltextzugriff (PDF)

PM20D1 is a circulating biomarker closely associated with obesity, insulin resistance and metabolic syndrome

European journal of endocrinology, 2022-02, Vol.186 (2), p.151

2022

Volltextzugriff (PDF)

Development of a Non-Invasive Liver Fibrosis Score Based on Transient Elastography for Risk Stratification in Patients with Type 2 Diabetes

Endocrinology and metabolism (Seoul), 2021-03, Vol.36 (1), p.134-145

2021

Volltextzugriff (PDF)

Development of a Non-Invasive Liver Fibrosis Score Based on Transient Elastography for Risk Stratification in Patients with Type 2 Diabetes

Endocrinology and Metabolism, 2021, 36(1), , pp.134-145

2021

Volltextzugriff (PDF)

Glycogenic hepatopathy as an unusual etiology of deranged liver function in a patient with type 1 diabetes: A case report

Medicine (Baltimore), 2019-04, Vol.98 (17), p.e15296-e15296

2019

Volltextzugriff (PDF)

Obesity‐induced insulin resistance and macrophage infiltration of the adipose tissue: A vicious cycle

Journal of diabetes investigation, 2019-01, Vol.10 (1), p.29-31

2019

Volltextzugriff (PDF)

Erratum. Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans. Diabetes 2008;57:1246-1253

Diabetes (New York, N.Y.), 2019-01, Vol.68 (1), p.235-235

2019

Volltextzugriff (PDF)

Declining Trends of Cardiovascular-Renal Complications and Mortality in Type 2 Diabetes: The Hong Kong Diabetes Database

Diabetes care, 2017-07, Vol.40 (7), p.928-935

2017

Volltextzugriff (PDF)

Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis

Endocrinology and metabolism (Seoul), 2017-06, Vol.32 (2), p.145-151

2017

Volltextzugriff (PDF)

An Exome-Chip Association Analysis in Chinese Subjects Reveals a Functional Missense Variant of GCKR That Regulates FGF21 Levels

Diabetes (New York, N.Y.), 2017-06, Vol.66 (6), p.1723-1728

2017

Volltextzugriff (PDF)

Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis

Endocrinology and Metabolism, 2017, 32(2), , pp.145-151

2017

Volltextzugriff (PDF)

Serum fibroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes

Clinical endocrinology (Oxford), 2017-01, Vol.86 (1), p.37-43

2017

Volltextzugriff (PDF)

Heterogeneity of white adipose tissue: molecular basis and clinical implications

Experimental and Molecular Medicine, 2016, 48(0), , pp.1-12

2016

Volltextzugriff (PDF)

Diabetes is associated with increased risks of low lean mass and slow gait speed when peripheral artery disease is present

Journal of diabetes and its complications, 2016-03, Vol.30 (2), p.306-311

2016

Volltextzugriff (PDF)

Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation

Scientific reports, 2016-01, Vol.6 (1), p.19776-19776, Article 19776

2016

Volltextzugriff (PDF)

Evaluation of Cutpoints for Low Lean Mass and Slow Gait Speed in Predicting Death in the National Health and Nutrition Examination Survey 1999-2004

The journals of gerontology. Series A, Biological sciences and medical sciences, 2016-01, Vol.71 (1), p.90-95

2016

Volltextzugriff (PDF)

Obstructive sleep apnoea, insulin resistance and adipocytokines

Clinical endocrinology (Oxford), 2015-02, Vol.82 (2), p.165-177

2015

Volltextzugriff (PDF)

Increased Neutrophil Elastase and Proteinase 3 and Augmented NETosis Are Closely Associated With [Beta]-Cell Autoimmunity in Patients With Type 1 Diabetes

Diabetes (New York, N.Y.), 2014-12, Vol.63 (12), p.4239

2014

Volltextzugriff (PDF)

FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting

Diabetes (New York, N.Y.), 2014-12, Vol.63 (12), p.4064-4075

2014

Volltextzugriff (PDF)

Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes

Diabetes (New York, N.Y.), 2014-12, Vol.63 (12), p.4239-4248

2014

Volltextzugriff (PDF)

The adaptor protein APPL2 inhibits insulin-stimulated glucose uptake by interacting with TBC1D1 in skeletal muscle

Diabetes (New York, N.Y.), 2014-11, Vol.63 (11), p.3748-3758

2014

Volltextzugriff (PDF)

Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA

BMC medicine, 2014-09, Vol.12 (1), p.154, Article 154

2014

Volltextzugriff (PDF)

Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1[alpha]-mediated antioxidant capacity in mice

Hepatology (Baltimore, Md.), 2014-09, Vol.60 (3), p.977

2014

Volltextzugriff (PDF)

The clinical significance of aldosterone synthase deficiency: report of a novel mutation in the CYP11B2 gene

BMC endocrine disorders, 2014-04, Vol.14 (1), p.29-29, Article 29

2014

Volltextzugriff (PDF)

High glucose represses [beta]-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator--activated receptor [gamma] signaling

Diabetes (New York, N.Y.), 2013-11, Vol.62 (11), p.3751

2013

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(74)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(54)
Humans
(41)
Male
(29)
Female
(26)
Endocrinology & Metabolism
(24)
Middle Aged
(21)
Aged
(19)
Biological And Medical Sciences
(19)
Adult
(18)
Diabetes
(18)
Insulin Resistance
(17)
Medical Sciences
(17)
Animals
(16)
Obesity
(15)
Mice
(13)
Risk Factors
(13)
Proteins
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)
Glucose
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Non‐alcoholic fatty liver disease and type 2 diabetes: An update

PM20D1 is a circulating biomarker closely associated with obesity, insulin resistance and metabolic syndrome

Development of a Non-Invasive Liver Fibrosis Score Based on Transient Elastography for Risk Stratification in Patients with Type 2 Diabetes

Development of a Non-Invasive Liver Fibrosis Score Based on Transient Elastography for Risk Stratification in Patients with Type 2 Diabetes

Glycogenic hepatopathy as an unusual etiology of deranged liver function in a patient with type 1 diabetes: A case report

Obesity‐induced insulin resistance and macrophage infiltration of the adipose tissue: A vicious cycle

Erratum. Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans. Diabetes 2008;57:1246-1253

Declining Trends of Cardiovascular-Renal Complications and Mortality in Type 2 Diabetes: The Hong Kong Diabetes Database

Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis

An Exome-Chip Association Analysis in Chinese Subjects Reveals a Functional Missense Variant of GCKR That Regulates FGF21 Levels

Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis

Serum fibroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes

Heterogeneity of white adipose tissue: molecular basis and clinical implications

Diabetes is associated with increased risks of low lean mass and slow gait speed when peripheral artery disease is present

Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation

Evaluation of Cutpoints for Low Lean Mass and Slow Gait Speed in Predicting Death in the National Health and Nutrition Examination Survey 1999-2004

Obstructive sleep apnoea, insulin resistance and adipocytokines

Increased Neutrophil Elastase and Proteinase 3 and Augmented NETosis Are Closely Associated With [Beta]-Cell Autoimmunity in Patients With Type 1 Diabetes

FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting

Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes

The adaptor protein APPL2 inhibits insulin-stimulated glucose uptake by interacting with TBC1D1 in skeletal muscle

Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA

Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1[alpha]-mediated antioxidant capacity in mice

The clinical significance of aldosterone synthase deficiency: report of a novel mutation in the CYP11B2 gene

High glucose represses [beta]-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator--activated receptor [gamma] signaling

Suchergebnisse filtern